$966 Million is the total value of Soleus Capital Management, L.P.'s 77 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 81.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SER TRcall | $158,516,800 | – | 2,080,000 | +100.0% | 16.42% | – |
| EDAP | Buy | EDAP TMS S Asponsored adr | $58,806,298 | +7.4% | 5,312,222 | +3.5% | 6.09% | -22.4% |
| ISEE | Buy | IVERIC BIO INC | $51,750,956 | +14.3% | 2,127,043 | +0.6% | 5.36% | -17.5% |
| Buy | ARCELLX INC | $38,455,409 | +12.6% | 1,248,147 | +13.2% | 3.98% | -18.7% | |
| CRL | Buy | CHARLES RIV LABS INTL INC | $31,503,295 | +42.0% | 156,096 | +53.3% | 3.26% | +2.4% |
| EXAS | Buy | EXACT SCIENCES CORP | $30,955,265 | +117.6% | 456,500 | +58.9% | 3.21% | +57.1% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $30,511,191 | -14.5% | 136,235 | +6.2% | 3.16% | -38.2% |
| IRMD | Buy | IRADIMED CORP | $30,444,859 | +44.5% | 773,694 | +3.9% | 3.15% | +4.3% |
| SNN | New | SMITH & NEPHEW PLCspdn adr new | $27,078,282 | – | 970,200 | +100.0% | 2.80% | – |
| ORGO | Buy | ORGANOGENESIS HLDGS INC | $20,987,024 | +6.0% | 9,853,063 | +33.8% | 2.17% | -23.5% |
| SIBN | New | SI-BONE INC | $20,869,536 | – | 1,060,983 | +100.0% | 2.16% | – |
| SRDX | Buy | SURMODICS INC | $20,335,205 | -23.1% | 892,678 | +15.1% | 2.11% | -44.5% |
| CVS | Buy | CVS HEALTH CORP | $18,098,498 | +105.0% | 243,554 | +157.0% | 1.87% | +47.9% |
| CELC | Buy | CELCUITY INC | $17,301,313 | +2.0% | 1,687,933 | +39.5% | 1.79% | -26.3% |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $16,899,980 | – | 12,803,015 | +100.0% | 1.75% | – |
| AXGN | Buy | AXOGEN INC | $16,820,981 | +122.9% | 1,779,998 | +135.5% | 1.74% | +61.0% |
| NTRA | New | NATERA INC | $16,333,984 | – | 294,200 | +100.0% | 1.69% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $15,873,905 | – | 174,592 | +100.0% | 1.64% | – |
| SGEN | New | SEAGEN INC | $14,375,370 | – | 71,000 | +100.0% | 1.49% | – |
| PCVX | Sell | VAXCYTE INC | $14,251,770 | -23.4% | 380,250 | -2.0% | 1.48% | -44.7% |
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $13,766,094 | +9.9% | 1,089,952 | -20.8% | 1.43% | -20.6% |
| New | JASPER THERAPEUTICS INC | $13,493,514 | – | 7,454,980 | +100.0% | 1.40% | – | |
| EPIX | Buy | ESSA PHARMA INC | $12,310,997 | +26.3% | 4,145,117 | +7.1% | 1.28% | -8.9% |
| BCAB | Buy | BIOATLA INC | $11,580,808 | -66.7% | 4,321,197 | +2.4% | 1.20% | -76.0% |
| HUM | Sell | HUMANA INC | $11,529,675 | -15.8% | 23,750 | -11.2% | 1.19% | -39.3% |
| TGTX | Buy | TG THERAPEUTICS INC | $11,284,512 | +300.8% | 750,300 | +215.3% | 1.17% | +189.4% |
| NPCE | Buy | NEUROPACE INC | $11,269,233 | +219.3% | 2,428,714 | +2.5% | 1.17% | +130.6% |
| VCEL | Sell | VERICEL CORP | $9,571,485 | -60.0% | 326,449 | -64.1% | 0.99% | -71.1% |
| LNTH | New | LANTHEUS HLDGS INC | $9,387,072 | – | 113,700 | +100.0% | 0.97% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $8,858,137 | – | 1,449,777 | +100.0% | 0.92% | – |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $8,758,986 | +14.5% | 411,800 | +59.4% | 0.91% | -17.3% |
| INBX | Sell | INHIBRX INC | $8,265,098 | -29.9% | 438,002 | -8.4% | 0.86% | -49.4% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $8,256,013 | -41.2% | 203,300 | -34.9% | 0.86% | -57.6% |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $8,068,986 | +42.6% | 469,400 | +84.3% | 0.84% | +3.0% |
| NVCR | New | NOVOCURE LTD | $7,818,200 | – | 130,000 | +100.0% | 0.81% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $7,659,000 | – | 460,000 | +100.0% | 0.79% | – |
| ETNB | Buy | 89BIO INC | $7,523,620 | +55.9% | 494,000 | +30.3% | 0.78% | +12.6% |
| CCCC | Sell | C4 THERAPEUTICS INC | $7,495,243 | -48.0% | 2,387,020 | -2.2% | 0.78% | -62.4% |
| THTX | Buy | THERATECHNOLOGIES INC | $7,363,314 | -5.2% | 9,090,511 | +3.3% | 0.76% | -31.5% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $6,819,431 | -54.3% | 85,179 | -54.7% | 0.71% | -67.0% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $6,813,312 | +21.7% | 322,600 | +46.6% | 0.71% | -12.1% |
| New | GENEDX HOLDINGS CORP | $6,548,100 | – | 17,940,000 | +100.0% | 0.68% | – | |
| ALKS | New | ALKERMES PLC | $6,483,700 | – | 230,000 | +100.0% | 0.67% | – |
| NARI | Sell | INARI MED INC | $6,263,523 | -56.1% | 101,450 | -54.8% | 0.65% | -68.3% |
| New | NUVALENT INC | $6,180,721 | – | 236,900 | +100.0% | 0.64% | – | |
| KRTX | New | KARUNA THERAPEUTICS INC | $6,128,534 | – | 33,740 | +100.0% | 0.64% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $6,035,120 | – | 364,000 | +100.0% | 0.62% | – |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $5,812,840 | – | 242,000 | +100.0% | 0.60% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $5,276,154 | – | 234,600 | +100.0% | 0.55% | – |
| KROS | Sell | KEROS THERAPEUTICS INC | $5,222,893 | -53.3% | 122,316 | -47.5% | 0.54% | -66.3% |
| DICE THERAPEUTICS INC | $4,969,257 | -8.2% | 173,447 | 0.0% | 0.52% | -33.6% | ||
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $4,711,826 | -26.5% | 116,514 | -15.5% | 0.49% | -47.0% |
| New | MINERALYS THERAPEUTICS INC | $4,278,954 | – | 273,241 | +100.0% | 0.44% | – | |
| PIRS | Buy | PIERIS PHARMACEUTICALS INC | $4,035,631 | +288.0% | 4,134,868 | +313.5% | 0.42% | +180.5% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $3,780,450 | – | 155,000 | +100.0% | 0.39% | – |
| ABCM | New | ABCAM PLCads | $3,768,410 | – | 279,971 | +100.0% | 0.39% | – |
| INSP | Sell | INSPIRE MED SYS INC | $3,651,492 | -68.6% | 15,600 | -66.2% | 0.38% | -77.4% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $3,575,800 | – | 190,000 | +100.0% | 0.37% | – |
| ANNX | New | ANNEXON INC | $3,524,290 | – | 915,400 | +100.0% | 0.36% | – |
| New | PARAGON 28 INC | $3,482,587 | – | 204,018 | +100.0% | 0.36% | – | |
| PHVS | Buy | PHARVARIS N V | $2,713,730 | -22.2% | 336,900 | +8.7% | 0.28% | -43.8% |
| FGEN | Buy | FIBROGEN INC | $2,415,780 | +32.9% | 129,463 | +14.1% | 0.25% | -4.2% |
| ANGO | New | ANGIODYNAMICS INC | $2,326,500 | – | 225,000 | +100.0% | 0.24% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $2,014,410 | – | 249,000 | +100.0% | 0.21% | – |
| CSII | New | CARDIOVASCULAR SYS INC DEL | $1,893,572 | – | 95,346 | +100.0% | 0.20% | – |
| Buy | AMYLYX PHARMACEUTICALS INC | $1,854,699 | -0.9% | 63,214 | +24.8% | 0.19% | -28.4% | |
| PARDES BIOSCIENCES INC | $1,650,000 | -21.9% | 1,250,000 | 0.0% | 0.17% | -43.6% | ||
| TMDX | Sell | TRANSMEDICS GROUP INC | $1,438,870 | -46.4% | 19,000 | -56.3% | 0.15% | -61.3% |
| New | RXSIGHT INC | $1,334,400 | – | 80,000 | +100.0% | 0.14% | – | |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $1,276,776 | -66.9% | 20,700 | -58.6% | 0.13% | -76.1% |
| LYRA | LYRA THERAPEUTICS INC | $1,190,758 | -36.0% | 592,417 | 0.0% | 0.12% | -53.9% | |
| New | ORCHESTRA BIOMED HLDGS INC | $1,183,007 | – | 60,450 | +100.0% | 0.12% | – | |
| LUNG | PULMONX CORP | $793,780 | +32.6% | 71,000 | 0.0% | 0.08% | -4.7% | |
| XILIO THERAPEUTICS INC | $719,403 | +17.8% | 226,941 | 0.0% | 0.07% | -15.9% | ||
| IMUX | New | IMMUNIC INC | $447,000 | – | 300,000 | +100.0% | 0.05% | – |
| YMAB | Y-MABS THERAPEUTICS INC | $436,782 | +2.7% | 87,182 | 0.0% | 0.04% | -26.2% | |
| New | MDXHEALTH SAsponsored ads | $194,400 | – | 60,000 | +100.0% | 0.02% | – | |
| Exit | PEPGEN INC | $0 | – | -10,000 | -100.0% | -0.02% | – | |
| KIDS | Exit | ORTHOPEDIATRICS CORP | $0 | – | -7,471 | -100.0% | -0.04% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -14,727 | -100.0% | -0.06% | – |
| CUTR | Exit | CUTERA INC | $0 | – | -20,000 | -100.0% | -0.13% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -22,000 | -100.0% | -0.13% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -38,000 | -100.0% | -0.22% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -78,000 | -100.0% | -0.29% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -9,300 | -100.0% | -0.30% | – |
| NEOG | Exit | NEOGEN CORP | $0 | – | -143,500 | -100.0% | -0.31% | – |
| Exit | VENTYX BIOSCIENCES INC | $0 | – | -69,000 | -100.0% | -0.32% | – | |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -9,600 | -100.0% | -0.36% | – |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -70,000 | -100.0% | -0.37% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -236,000 | -100.0% | -0.37% | – |
| ESTA | Exit | ESTABLISHMENT LABS HLDGS INC | $0 | – | -39,920 | -100.0% | -0.38% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -31,100 | -100.0% | -0.49% | – |
| BLI | Exit | BERKELEY LTS INC | $0 | – | -1,330,000 | -100.0% | -0.51% | – |
| Exit | IMAGO BIOSCIENCES INC | $0 | – | -115,000 | -100.0% | -0.59% | – | |
| DXCM | Exit | DEXCOM INC | $0 | – | -40,000 | -100.0% | -0.65% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -24,262 | -100.0% | -0.70% | – |
| Exit | ENOVIS CORPORATION | $0 | – | -95,000 | -100.0% | -0.73% | – | |
| STAA | Exit | STAAR SURGICAL CO | $0 | – | -110,200 | -100.0% | -0.77% | – |
| OFIX | Exit | ORTHOFIX MED INC | $0 | – | -295,300 | -100.0% | -0.87% | – |
| AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -217,119 | -100.0% | -0.91% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -310,000 | -100.0% | -0.99% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -34,550 | -100.0% | -1.19% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -39,100 | -100.0% | -2.05% | – |
| CVRX | Exit | CVRX INC | $0 | – | -1,014,640 | -100.0% | -2.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.